![Lisa Bissett](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Lisa Bissett
Geen lopende functies
Profiel
Ms. Lisa Bissett is a Manager-Regulatory Affairs at Proveca Ltd.
Ms. Bissett was previously employed as Head-Regulatory by Sinclair IS Pharma Plc.
Eerdere bekende functies van Lisa Bissett
Bedrijven | Functie | Einde |
---|---|---|
Proveca Ltd.
![]() Proveca Ltd. Pharmaceuticals: MajorHealth Technology Proveca Ltd. develops pharmaceuticals for children and adults through studies dedicated to providing evidence for the specific use of off-patent medicines. The firm develops medicines for children in the fields of cardiology, neurology, and pain management. The company was founded by Simon Peter Bryson and Helen Margaret Shaw in July 2010 and is headquartered in Warrington, the United Kingdom. | Algemeen Adviseur | - |
SINCLAIR PHARMA PLC | Algemeen Adviseur | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Sinclair Pharma Ltd.
![]() Sinclair Pharma Ltd. Medical SpecialtiesHealth Technology Sinclair Pharma Ltd. operates as an aesthetic dermatology company which provides solutions through collagen stimulation for facial volume loss, thread lifting for facial contouring, and dermal fillers for wrinkles and lines. It operates through the following business segments: Country Operations and International Operations. The Country Operations segment comprises the proprietary sales infrastructure from the operations in France, the United Kingdom, Italy, Germany, and Spain. The International Operations segment focuses on the sale through a local distributor. The company was founded in 1971 and is headquartered in London, the United Kingdom. | Health Technology |
Proveca Ltd.
![]() Proveca Ltd. Pharmaceuticals: MajorHealth Technology Proveca Ltd. develops pharmaceuticals for children and adults through studies dedicated to providing evidence for the specific use of off-patent medicines. The firm develops medicines for children in the fields of cardiology, neurology, and pain management. The company was founded by Simon Peter Bryson and Helen Margaret Shaw in July 2010 and is headquartered in Warrington, the United Kingdom. | Health Technology |